Pneumococcal Disease: Current Concepts for At-Risk Adults

Improve your knowledge on pneumococcal disease, its serotypes and clinical presentation, key differences in new and emerging vaccines, and strategies for prevention among at-risk adults through a series of expert-written ClinicalThought commentaries, living slides, and a clinical focus module.

Share

Program Content

Activities

Pneumococcal Diseases
New Data on Pneumococcal Diseases and Vaccines From ESCMID Global 2024 and ISPPD-13
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: June 14, 2024

Expires: June 13, 2025

Pneumococcal Vaccines
Pneumococcal Vaccines for Adults: A Matter of Choice?
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: September 16, 2024

Expires: September 15, 2025

Activities

Pneumococcal Disease EU
Pneumococcal Disease: Current Concepts for At-Risk Adults
Text Module
Congratulations: You achieved a completion on 04/09/2022

Released: August 22, 2024

Expires: August 21, 2025

Activities

Pneumococcal Disease Slides
Pneumococcal Disease: Current Concepts for At-Risk Adults
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: August 21, 2024

Expires: August 20, 2025

Faculty

cover img faculity

Elisabeth Botelho-Nevers, MD, PhD, HDR

Full Professor in Infectious Diseases
Head of Infectious Disease Department
University Hospital Saint-Etienne
CIRI Lab, Team GIMAP, Inserm, U1111, CNRS, UMR530
Chair Prevention, Vaccination, Controle de l’infection - PRESAGE
University of Saint-Etienne
Saint-Etienne, France

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC

Supporters

This activity is supported through an independent educational grant from Merck & Co., Inc., Rahway, NJ, USA.

Merck & Co., Inc., Rahway, NJ, USA